Note 7. Accounts Receivable

              At March 31, 2024 and December 31, 2023, accounts receivable consisted of the following (in thousands):

The Company increased the allowance for credit losses in the amount of approximately $2,000 and $0 for the three months ended March 31, 2024 and 2023, respectively. 

Accounts receivable – trade, net for the Company as of January 1, 2023 and  March 31, 2023 were approximately $0.4 million and $1.0 million, respectively.

Note 8. Accounts Receivable

At December 31, 2023 and 2022, accounts receivable consisted of the following (in thousands):

Bad debt expense was approximately $47,000 and $0 for the twelve months ended December 31, 2023 and 2022, respectively.

The increase in accounts receivable was attributable to the consolidation of Progressive Care at July 1, 2023.